Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management

IJ Neeland, P Poirier, JP Després - Circulation, 2018 - Am Heart Assoc
The prevalence of obesity has increased globally over the last 2 decades. Although the body
mass index has been a convenient and simple index of obesity at the population level …

Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap

SJ Shah, DW Kitzman, BA Borlaug, L Van Heerebeek… - Circulation, 2016 - Am Heart Assoc
Heart failure (HF) with preserved ejection fraction (EF; HFpEF) accounts for 50% of HF
cases, and its prevalence relative to HF with reduced EF continues to rise. In contrast to HF …

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

AM Jackson, PS Jhund, IS Anand… - European heart …, 2021 - academic.oup.com
Aims Patients with heart failure and preserved ejection fraction (HFpEF) frequently have
difficult-to-control hypertension. We examined the effect of neprilysin inhibition on 'apparent …

Characterization of the inflammatorymetabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution …

M Packer, CSP Lam, LH Lund… - European Journal of …, 2020 - Wiley Online Library
Accumulating evidence points to the existence of an inflammatorymetabolic phenotype of
heart failure with a preserved ejection fraction (HFpEF), which is characterized by …

The role of zinc and copper in insulin resistance and diabetes mellitus

G Bjørklund, M Dadar, L Pivina… - Current medicinal …, 2020 - ingentaconnect.com
The prevalence of Type 2 Diabetes Mellitus (T2DM) is internationally ever-growing.
Therefore, prevention, diagnostics, and control of insulin resistance and T2DM are of …

Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions

AE Peters, J Tromp, SJ Shah, CSP Lam… - Cardiovascular …, 2022 - academic.oup.com
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity with
complex pathophysiology and manifestations. Phenomapping is the process of applying …

Physical activity ameliorates the function of organs via adipose tissue in metabolic diseases

N Abedpoor, F Taghian, F Hajibabaie - Acta histochemica, 2022 - Elsevier
Adipose tissue is a dynamic organ in the endocrine system that can connect organs by
secreting molecules and bioactive. Hence, adipose tissue really plays a pivotal role in …

Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events

R Kerkelä, J Ulvila, J Magga - Journal of the American Heart …, 2015 - Am Heart Assoc
(BNP), and C-type natriuretic peptide (CNP) are the known members of the mammalian
natriuretic peptide system. The discovery of natriuretic peptides (NPs) dates back to 1981 …

Sex-based differences in cardiometabolic biomarkers

J Lew, M Sanghavi, CR Ayers, DK McGuire, T Omland… - Circulation, 2017 - Am Heart Assoc
Background: Few data are available comparing cardiovascular disease (CVD) biomarker
profiles between women and men in the general population. We analyzed sex-based …

Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention …

M Volpe, G Gallo - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
The prevalence of obesity worldwide has increased in recent decades not only among
adults, but also in children and adolescents. This phenomenon contributes to an increased …